Startups
Korro Secures $85M Lifeline After Trial Setback
Cambridge biotech raises funds to advance RNA-editing programs after lead candidate misses targets
Abselion Establishes US Subsidiary in Cambridge, MA
The UK-based tech company expands operations to the United States.
Seres Therapeutics appoints Kender as exec chair, interim CEO
Upcoming SER-155 data and $45.8M cash runway frame Seres' shift to microbiome drugs as Richard Kender steps in as interim CEO.
Industry
Moderna to Pay Up to $2.25B to Settle COVID Vaccine Patent Dispute
Moderna reaches deal with Genevant Sciences and Arbutus Biopharma over lipid nanoparticle technology used in its COVID-19 vaccine.
Massachusetts Tax Board Grants Property Tax Exemption to Taxpayer Energy Company
Ruling allows company to avoid property taxes in Cambridge under state manufacturing exemption.
Amylyx Pharmaceuticals Focuses on Advancing Avexitide for Post-Bariatric Hypoglycemia
Company also provides updates on pipeline programs AMX0318, AMX0114, and AMX0035
Public Companies
Moderna to Pay Up to $2.25B to Settle COVID Vaccine Patent Dispute
Moderna reaches deal with Genevant Sciences and Arbutus Biopharma over technology used in its COVID-19 vaccine.
Handelsbanken Fonder AB Increases Stake in Pegasystems Inc.
The Swedish investment firm raised its holdings in the software company by 45.3% in the third quarter.
Akebia Therapeutics Reports Inducement Grants
Biopharmaceutical company grants stock options to new hires under Nasdaq rule
